Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_04251
Species: Homo sapiens
Position : chr7:117504671-117505671
Year: 2022
Title: Epigenome editing of the CFTR-locus for treatment of cystic fibrosis.
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: cystic fibrosis
PMID:  34049825
MONDO: MONDO:0009061
Tissue: lung
Tissue Ontology ID: UBERON:0002048
Cell Source: UNCCF3T (F508del/F508del human bronchial epithelial cells)
Cell Type: bronchial epithelial cell
Cell Ontology ID: CL:0002328
Experiment Type: Epigenome editing assay; Functional enhancer perturbation assay
High Throughput Method: Published epigenomic prioritization of CFTR regulatory regions
Low Throughput Method: dCas9-p300 enhancer activation; dCas9-KRAB enhancer repression; RT-qPCR; CFTR protein assay; Ussing chamber assay
About Target Gene
Target gene : CFTR
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg38) 1 found
Enhancer ID Position Tissue Cell Disease
E_04243 chr7:117504671-117505671 kidney embryonic kidney cell NA
Expression of Target Genes for the Enhancer